Search

Your search keyword '"Samuel, CS"' showing total 277 results

Search Constraints

Start Over You searched for: Author "Samuel, CS" Remove constraint Author: "Samuel, CS" Database MEDLINE Remove constraint Database: MEDLINE
277 results on '"Samuel, CS"'

Search Results

1. Thermal imaging through hot emissive windows.

2. The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo.

3. Loss of Bicra/Gltscr1 leads to a defect in fetal liver macrophages responsible for erythrocyte maturation in mice.

4. Sex- and time-dependent role of insulin regulated aminopeptidase in lipopolysaccharide-induced inflammation.

5. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness.

6. Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis.

7. Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles.

8. The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin.

9. SMC-5/6 complex subunit NSE-1 plays a crucial role in meiosis and DNA repair in Caenorhabditis elegans.

10. Anxiety and its risk factors among non-Japanese residents living in Japan undergoing COVID-19 situation: A cross-sectional survey.

11. IL-4 and IL-13 induce equivalent expression of traditional M2 markers and modulation of reactive oxygen species in human macrophages.

13. Caenorhabditis elegans NSE3 homolog (MAGE-1) is involved in genome stability and acts in inter-sister recombination during meiosis.

14. Novel AT 2 R agonist, β-Pro 7 Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats.

15. Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.

16. The protective effects of a novel AT 2 receptor agonist, β-Pro 7 Ang III in ischemia-reperfusion kidney injury.

17. Does environment quality affect the health care spending? Nexus among CO 2 emissions, non-renewable energy production, financial development, and health care spending.

18. A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.

19. The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy.

20. The dynamic relationship between green tax incentives and environmental protection.

21. Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice.

22. Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis.

23. Determination of Interstitial Collagen Deposition and Related Topography Using the Second Harmonic Generation-Based HistoIndex Platform.

24. Do drivers of renewable energy consumption matter for BRICS economies? Nexus among technological innovation, environmental degradation, economic growth, and income inequality.

25. Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer's Disease.

26. Post-stroke administration of H2 relaxin reduces functional deficits, neuronal apoptosis and immune cell infiltration into the mouse brain.

28. Can money supply endogeneity influence bank stock returns? A case study of South Asian economies.

29. Morphological and morphometric studies on the axial skeleton of the sitatunga (Tragelaphus spekii gratus).

30. The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice.

31. Sulforaphane prevents and reverses allergic airways disease in mice via anti-inflammatory, antioxidant, and epigenetic mechanisms.

32. Targeting angiopoietin-2 as a novel treatment option for kidney fibrosis.

33. The relationship between staple food crops consumption and its impact on total factor productivity: does green economy matter?

34. A New Method to Protect Blood Supply in the Treatment of Femoral Neck Fractures: Bidirectional Compression Porous Tantalum Screws.

35. An endogenous mCherry-tagged COSA-1 as a crossover investigation tool in Caenorhabditis elegans .

36. Loss of NSE-4 Perturbs Genome Stability and DNA Repair in Caenorhabditis elegans .

37. Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors.

38. Gross morphological and morphometric study of the upper respiratory system of the African giant rat (Cricetomys gambianus, Waterhouse 1840).

39. Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.

40. The Placental NLRP3 Inflammasome and Its Downstream Targets, Caspase-1 and Interleukin-6, Are Increased in Human Fetal Growth Restriction: Implications for Aberrant Inflammation-Induced Trophoblast Dysfunction.

41. A Novel Approach to Enhance the Regenerative Potential of Circulating Endothelial Progenitor Cells in Patients with End-Stage Kidney Disease.

42. Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions.

43. Expansion of the composition library for chemodiversity of hardwood extractives at molecular level by ultrahigh-resolution mass spectrometry.

44. Preclinical rodent models of cardiac fibrosis.

45. Immune Mechanisms and Related Targets for the Treatment of Fibrosis in Various Organs.

46. The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosis.

47. Modern Management of the Appendix: So Many Options.

48. Does digitalization matter in green preferences in nexus of output volatility and environmental quality?

49. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.

Catalog

Books, media, physical & digital resources